- Home
- NAN vs PALI Comparison
NAN vs PALI Comparison
Compare NAN & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NAN | PALI |
|---|---|---|
| Founded | 1999 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 355.4M | 359.7M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | NAN | PALI |
|---|---|---|
| Price | $11.59 | $1.86 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $11.29 |
| AVG Volume (30 Days) | 63.2K | ★ 2.6M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | ★ 4.37% | N/A |
| EPS Growth | N/A | ★ 97.06 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $260,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1500.39 |
| 52 Week Low | $10.79 | $0.55 |
| 52 Week High | $11.67 | $2.86 |
Technical Indicators
Market Signals| Indicator | NAN | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 62.79 | 50.65 |
| Support Level | $11.34 | $1.57 |
| Resistance Level | $11.60 | $2.12 |
| Average True Range (ATR) | 0.09 | 0.14 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 86.96 | 46.00 |
Price Performance
Historical ComparisonAbout NAN Nuveen New York Quality Municipal Income Fund
Nuveen New York Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.